{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain specific molecule names, IDs, or other identifiers along with bioactivity metrics, numeric values, and units. It primarily discusses general concepts, definitions, and methods related to antibodies and antigen-binding interactions without providing specific data that includes all four required components."}
{"raw_mentions": "The experiments in examples prove that the antibody according to the present invention has excellent binding ability for the ITGA2 protein (EC50<1 nM), and also has excellent binding ability to HuCCT1 cells that highly express ITGA2 (EC50<5 nM)."}
{"final_json": [{"molecule_name": "antibody", "protein_target_name": "ITGA2", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "<1", "unit": "nM"}, {"molecule_name": "antibody", "protein_target_name": "ITGA2", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "<5", "unit": "nM"}]}
{"raw_mentions": "In some embodiments, the antibody or the antigen-binding fragment thereof is capable of binding the ITGA2 protein in vitro at an EC50 of less than 1 nM.\nIn some embodiments, the antibody or the antigen-binding fragment thereof is capable of binding to an ITGA2 protein on the surface of HuCCT1 cells with an EC50 of less than 5 nM."}
{"final_json": [{"molecule_name": null, "protein_target_name": "ITGA2", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "<1", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "ITGA2", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "<5", "unit": "nM"}]}
{"raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nThe results are shown in Table 6 below.\nFS002-A10.029\nFS002-A100.021\nFS002-A150.028\nFS002-A360.022\nFS002-A50.032\nFS002-A660.031\nFS002-A720.259\nFS002-B270.571\nFS002-C110.035\nFS002-C150.044\nFS002-C1530.087\nFS002-C2160.073\nFS002-C2410.116\nFS002-C3300.103\nFS002-C3750.073\nFS002-C4170.156\nFS002-C580.279\nFS002-C912.080\nVatelizumab0.023\nThe results of the determination of EC50 are shown in Table 7.\nFS002-A10.653\nFS002-A101.127\nFS002-A150.927\nFS002-A360.793\nFS002-A51.267\nFS002-A662.353\nFS002-A7217.213\nFS002-B272.753\nFS002-C110.747\nFS002-C152.133\nFS002-C1533.627\nFS002-C2160.987\nFS002-C2412.413\nFS002-C3302.067\nFS002-C3752.167\nFS002-C41768.400\nFS002-C589.480\nFS002-C934.560\nVatelizumab0.793\nAs shown in the table above, 17 of the 18 tested antibodies have good binding activity to ITGA2-His (EC50&lt;1 nM).\nAs shown in Table 7, 14 of these 18 antibodies have EC50 of less than 5 nM and bind well to ITGA2-positive HuCCT1 cells."}
{"final_json": [{"molecule_name": "FS002-A10", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.029", "unit": null}, {"molecule_name": "FS002-A100", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.021", "unit": null}, {"molecule_name": "FS002-A150", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.028", "unit": null}, {"molecule_name": "FS002-A360", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.022", "unit": null}, {"molecule_name": "FS002-A50", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.032", "unit": null}, {"molecule_name": "FS002-A660", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.031", "unit": null}, {"molecule_name": "FS002-A720", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.259", "unit": null}, {"molecule_name": "FS002-B270", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.571", "unit": null}, {"molecule_name": "FS002-C110", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.035", "unit": null}, {"molecule_name": "FS002-C150", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.044", "unit": null}, {"molecule_name": "FS002-C1530", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.087", "unit": null}, {"molecule_name": "FS002-C2160", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.073", "unit": null}, {"molecule_name": "FS002-C2410", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.116", "unit": null}, {"molecule_name": "FS002-C3300", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.103", "unit": null}, {"molecule_name": "FS002-C3750", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.073", "unit": null}, {"molecule_name": "FS002-C4170", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.156", "unit": null}, {"molecule_name": "FS002-C580", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.279", "unit": null}, {"molecule_name": "FS002-C912", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.080", "unit": null}, {"molecule_name": "Vatelizumab", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.023", "unit": null}, {"molecule_name": "FS002-A10", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.653", "unit": null}, {"molecule_name": "FS002-A101", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.127", "unit": null}, {"molecule_name": "FS002-A150", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.927", "unit": null}, {"molecule_name": "FS002-A360", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.793", "unit": null}, {"molecule_name": "FS002-A51", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.267", "unit": null}, {"molecule_name": "FS002-A662", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.353", "unit": null}, {"molecule_name": "FS002-A7217", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.213", "unit": null}, {"molecule_name": "FS002-B272", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.753", "unit": null}, {"molecule_name": "FS002-C110", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.747", "unit": null}, {"molecule_name": "FS002-C152", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.133", "unit": null}, {"molecule_name": "FS002-C1533", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.627", "unit": null}, {"molecule_name": "FS002-C2160", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.987", "unit": null}, {"molecule_name": "FS002-C2412", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.413", "unit": null}, {"molecule_name": "FS002-C3302", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.067", "unit": null}, {"molecule_name": "FS002-C3752", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.167", "unit": null}, {"molecule_name": "FS002-C41768", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.400", "unit": null}, {"molecule_name": "FS002-C589", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.480", "unit": null}, {"molecule_name": "FS002-C934", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.560", "unit": null}, {"molecule_name": "Vatelizumab", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.793", "unit": null}, {"molecule_name": null, "protein_target_name": "ITGA2", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "<1", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "ITGA2", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "<5", "unit": "nM"}]}
{"raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nThe results are shown in Table 9. As shown in Table 9, FS002-A1-vc-MMAE, FS002-A15-vc-MMAE, FS002-A36-vc-MMAE and Vatelizumab-ve-MMAE had good killing effect on HuCC-T1 and A431, but had no killing effect on negative control cells CHO.\nTable 9ADC NameHuCC-T1 cell killing IC50 (nM)A431 cell killing IC50 (nM)CHO cell killing IC50 (nM)hIgG1>207>207>207Vatelizumab>207>207>207hIgG 1-vc-MMAE86.6026.90>207FS002-A1-vc-MMAE0.140.14>207FS002-A15-vc-MMAE0.200.20>207FS002-A36-vc-MMAE0.080.02>207Vatelizumab-ve-MMAE0.890.08>207"}
{"final_json": [{"molecule_name": "hIgG1", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": ">207", "unit": "nM"}, {"molecule_name": "Vatelizumab", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": ">207", "unit": "nM"}, {"molecule_name": "hIgG 1-vc-MMAE", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "86.60", "unit": "nM"}, {"molecule_name": "hIgG 1-vc-MMAE", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "26.90", "unit": "nM"}, {"molecule_name": "hIgG 1-vc-MMAE", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": ">207", "unit": "nM"}, {"molecule_name": "FS002-A1-vc-MMAE", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "0.14", "unit": "nM"}, {"molecule_name": "FS002-A1-vc-MMAE", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "0.14", "unit": "nM"}, {"molecule_name": "FS002-A1-vc-MMAE", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": ">207", "unit": "nM"}, {"molecule_name": "FS002-A15-vc-MMAE", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "0.20", "unit": "nM"}, {"molecule_name": "FS002-A15-vc-MMAE", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "0.20", "unit": "nM"}, {"molecule_name": "FS002-A15-vc-MMAE", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": ">207", "unit": "nM"}, {"molecule_name": "FS002-A36-vc-MMAE", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "0.08", "unit": "nM"}, {"molecule_name": "FS002-A36-vc-MMAE", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "0.02", "unit": "nM"}, {"molecule_name": "FS002-A36-vc-MMAE", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": ">207", "unit": "nM"}, {"molecule_name": "Vatelizumab-ve-MMAE", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "0.89", "unit": "nM"}, {"molecule_name": "Vatelizumab-ve-MMAE", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "0.08", "unit": "nM"}, {"molecule_name": "Vatelizumab-ve-MMAE", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": ">207", "unit": "nM"}]}
{"raw_mentions": "wherein the antibody is capable of binding to an ITGA2 protein in vitro at an EC50 of less than 1 nM;\nwherein the antibody is capable of binding to an ITGA2 protein on the surface of HuCCT1 cells with an EC50 of less than 5 nM;"}
{"final_json": [{"molecule_name": "antibody", "protein_target_name": "ITGA2", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "<1", "unit": "nM"}, {"molecule_name": "antibody", "protein_target_name": "ITGA2", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "EC50", "value": "<5", "unit": "nM"}]}
